Thoratec (Pleasanton, Caifornia) shares took as much as a 20% trouncing at one point yesterday after the company reported Friday that it had issued a notice to hospitals following 27 reports concerning wear and tear to its HeartMate II Left Ventricular Assist System (LVAD) for end-stage heart failure. (Medical Device Daily)